1-20 of 96
Andrew K. Godwin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB381: Plasma microbiota as novel biomarkers of early epithelial ovarian cancer detection

Diane E. Mahoney, Prabhakar Chalise, Dong Pei, Rachel Griffard, Trisha Home, Harsh Pathak, Shahid Umar, Andrew K. Godwin
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB381.
https://doi.org/10.1158/1538-7445.AM2024-LB381
Published: 05 April 2024
View article titled, Abstract LB381: Plasma microbiota as novel biomarkers of early epithelial ovarian cancer detection
Journal Articles

Abstract 5215: Orphan noncoding RNA (oncRNA) liquid biopsy assay is prognostic for survival in patients with triple-negative breast cancer (TNBC) and residual disease

Rachel Yoder, Jennifer Yen, Mehran Karimzadeh, Joshua M. Staley, India Fernandez, Adam C. Heinrich, Fereydoun Hormozdiari, Jeffrey Gregg, Andrew K. Godwin, Irene Acerbi, Raaj Trivedi, Babak Alipanahi, Shane R. Stecklein, Priyanka Sharma
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5215.
https://doi.org/10.1158/1538-7445.AM2024-5215
Published: 22 March 2024
View article titled, Abstract 5215: Orphan noncoding RNA (oncRNA) liquid biopsy assay is prognostic for survival in patients with triple-negative breast cancer (TNBC) and residual disease
Journal Articles

Abstract B041: Modeling the malignant transformation of fallopian tube epithelium driven by extracellular vesicles cargos in an organ-on-chip microphysiological system

Didi Zha, Jared Sipes, Sagar Rayamajhi, Leonidas E. Bantis, Angela Russo, Harsh Pathak, Andrew K. Godwin, Joanna E. Burdette
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): B041.
https://doi.org/10.1158/1538-7445.OVARIAN23-B041
Published: 04 March 2024
View article titled, Abstract B041: Modeling the malignant transformation of fallopian tube epithelium driven by extracellular vesicles cargos in an organ-on-chip microphysiological system
Journal Articles

Abstract 3301: Ultrasensitive compartment-free digital phenotyping of circulating extracellular vesicles for diagnosis of Ewing sarcoma

Yunjie Wen, Vikalp Vishwakarma, Andrew K. Godwin, Yong Zeng
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3301.
https://doi.org/10.1158/1538-7445.AM2023-3301
Published: 04 April 2023
View article titled, Abstract 3301: Ultrasensitive compartment-free digital phenotyping of circulating extracellular vesicles for diagnosis of Ewing sarcoma
Journal Articles

Abstract 1565: Targeting of KIF11 and AURKA to improve outcomes in Ewing sarcoma

Soumya M. Turaga, Vikalp Vishwakarma, Stacey Hembruff, Rajni Puri, Priya Sabu, Glenson Samuel, Andrew K. Godwin
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1565.
https://doi.org/10.1158/1538-7445.AM2023-1565
Published: 04 April 2023
View article titled, Abstract 1565: Targeting of KIF11 and AURKA to improve outcomes in Ewing sarcoma
Journal Articles

Abstract 5334: Targeting the KIF15-TPX2 PPI to overcome KIF11 inhibitor resistance in epithelial ovarian cancer

Benjamin K. Gibbs, Justin T. Douglas, Rebecca J. Wates, Peter R. McDonald, Amy M. Whitaker, Cornelius N. Ndi, Harsh B. Pathak, Laurie A. Harned, Sarah A. Neuenswander, Melinda A. Broward, Bret D. Freudenthal, Anuradha Roy, Frank J. Schoenen, Andrew K. Godwin
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5334.
https://doi.org/10.1158/1538-7445.AM2023-5334
Published: 04 April 2023
View article titled, Abstract 5334: Targeting the KIF15-TPX2 PPI to overcome KIF11 inhibitor resistance in epithelial ovarian cancer
Journal Articles

Abstract 3351: Identification of novel biomarkers for high grade serous ovarian cancer screening via extracellular vesicle proteomic profiling

Camille V. Trinidad, Harsh B. Pathak, Shibo Cheng, Rashna Madan, Mihaela E. Sardiu, Leonidas E. Bantis, Yong Zeng, Andrew K. Godwin
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3351.
https://doi.org/10.1158/1538-7445.AM2023-3351
Published: 04 April 2023
View article titled, Abstract 3351: Identification of novel biomarkers for high grade serous ovarian cancer screening via extracellular vesicle proteomic profiling
Journal Articles

Abstract P6-14-08: Epithelial/stromal cross talks that induce malignant transition of human ductal carcinoma in situ

Aditi Rastogi, Fariba Behbod, Nicholas Navin, Jerome Lin, Linheng Li, Hua Li, Andrew K. Godwin, Alastair M. Thompson, Timothy Fields, Yan Hong
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P6-14-08.
https://doi.org/10.1158/1538-7445.SABCS22-P6-14-08
Published: 01 March 2023
View article titled, Abstract P6-14-08: Epithelial/stromal cross talks that induce malignant transition of human ductal carcinoma in situ
Journal Articles

Abstract P2-11-16: Computerized Measurements of Nuclear Morphology Features, Mitosis Rate, and Tubule Formation from H&E Images Predicts Disease-Free Survival in Patients with HR+ & LN+ Invasive Breast Cancer from SWOG S8814

Yuli Chen, William E. Barlow, Haojia Li, Cheng Lu, Andrew Janowczyk, German Corredor, Shridar Ganesan, Michael Feldman, Pingfu Fu, Hannah Gilmore, Kathy S. Albain, Lajos Pusztai, James Rae, Daniel Hayes, Andrew K. Godwin, Alastair M. Thompson, Anant Madabhushi
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-11-16.
https://doi.org/10.1158/1538-7445.SABCS22-P2-11-16
Published: 01 March 2023
View article titled, Abstract P2-11-16: Computerized Measurements of Nuclear Morphology Features, Mitosis Rate, and Tubule Formation from H&E Images Predicts Disease-Free Survival in Patients with HR+ & LN+ Invasive Breast Cancer from SWOG S8814
Journal Articles

Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative analysis from NeoPACT and NeoSTOP trials

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder, Joshua M. Staley, Roberto Salgado, Laia Paré, Benedetta Conte, Fara Brasó-Maristany, Anne O’Dea, Lauren Nye, Manana Elia, Deepti Satelli, Gregory Crane, Richard McKittrick, Qamar Khan, Andrew K. Godwin, Aleix Prat
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD11-07.
https://doi.org/10.1158/1538-7445.SABCS22-PD11-07
Published: 01 March 2023
View article titled, Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative analysis from NeoPACT and NeoSTOP trials
Journal Articles

Abstract P2-11-11: Computer analysis of nuclear morphology with Multiple Instance Learning Predicts Overall Survival for Node Positive Breast Cancer Patients from SWOG S8814: A Blinded Validation Study

Daniel Shao, William E. Barlow, Haojia Li, Cheng Lu, Kathy S. Albain, James Rae, Daniel F. Hayes, Andrew K. Godwin, Alastair M. Thompson, Anant Madabhushi, Lajos Pusztai
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-11-11.
https://doi.org/10.1158/1538-7445.SABCS22-P2-11-11
Published: 01 March 2023
View article titled, Abstract P2-11-11: Computer analysis of nuclear morphology with Multiple Instance Learning Predicts Overall Survival for Node Positive Breast Cancer Patients from SWOG S8814: A Blinded Validation Study
Journal Articles

Abstract PD1-06: Black patients with triple negative breast cancer (TNBC) have enriched stromal tumor infiltrating lymphocytes (sTILs) and receive preferential benefit from neoadjuvant immunotherapy

Shane R. Stecklein, Rachel Yoder, Roberto Salgado, Joshua M. Staley, Anne O’Dea, Lauren Nye, Manana Elia, Deepti Satelli, Gregory Crane, Richard McKittrick, Andrew K. Godwin, Qamar Khan, Priyanka Sharma
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD1-06.
https://doi.org/10.1158/1538-7445.SABCS22-PD1-06
Published: 01 March 2023
View article titled, Abstract PD1-06: Black patients with triple negative breast cancer (TNBC) have enriched stromal tumor infiltrating lymphocytes (sTILs) and receive preferential benefit from neoadjuvant immunotherapy
Journal Articles

Abstract 3457: Rebastinib, a TIE2 antagonist improves chemotherapy response in homologous recombination proficient epithelial ovarian cancer murine models

Vijayalaxmi G. Gupta, Katherine F. Roby, Harsh B. Pathak, Andrew K. Godwin, Sumedha Gunewardena, Dineo Khabele
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3457.
https://doi.org/10.1158/1538-7445.AM2022-3457
Published: 15 June 2022
View article titled, Abstract 3457: Rebastinib, a TIE2 antagonist improves chemotherapy response in homologous recombination proficient epithelial ovarian cancer murine models
Journal Articles

Abstract 5306: IRAK1: A novel TOLLway to target ovarian cancer

David Standing, Sumedha Gunewardena, Afreen A. Sayed, Michele T. Pritchard, Harsh B. Pathak, Andrew K. Godwin, Shariska Petersen, Dineo Khabele, Jensen A. Roy, Prasad Dandawate, Scott J. Weir, Shrikant Anant
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5306.
https://doi.org/10.1158/1538-7445.AM2022-5306
Published: 15 June 2022
View article titled, Abstract 5306: IRAK1: A novel TOLLway to target ovarian cancer
Journal Articles

Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer

Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, Anthony Rooney, Stephen Williamson, Gary Doolittle, Weijing Sun, Bruce F Kimler, Anne P O'Dea, Lauren E Nye, Joseph P McGuirk, Ziyan Pessetto, Lisa Haney, Nicole Balmaceda, Laura Mitchell, Karissa Finke, Maggie Nelson, Dinesh Pal Mudaranthakam, Natalie Streeter, Stephanie Lafaver, Jaimie Heldstab, Qamar J Khan
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P4-10-03.
https://doi.org/10.1158/1538-7445.SABCS21-P4-10-03
Published: 15 February 2022
View article titled, Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer
Journal Articles

Abstract P5-01-03: Mouse-intraductal (MIND): An in vivo model for studying the underlying mechanisms of DCIS malignancy

Aditi Rastogi, Jerome Lin, Yan Hong, Darlene Limback, Hanan S. Elsarraj, Haleigh Harper, Haley Haines, Hayley Hansford, Michael Ricci, Carolyn Kaufman, Emily Wedlock, Mingchu Xu, Jianhua Zhang, Lisa May, Terri Cusick, Marc Inciardi, Mark Redick, Jason Gatewood, Onalisa Winblad, Allison Aripoli, Ashley Huppe, Christa Balanoff, Jamie Wagner, Amanda Amin, Kelsey E. Larson, Lawrence Ricci, Ossama Tawfik, Hana Razek, Ruby O Meierotto, Rashna Madan, Andrew K. Godwin, Jeffrey Thompson, Susan G. Hilsenbeck, Andy Futreal, Alastair Thompson, E. Shelley Hwang, Fang Fan, Nicholas Navin, Fariba Behbod, Grand Challenge PRECISION Consortium
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-01-03.
https://doi.org/10.1158/1538-7445.SABCS21-P5-01-03
Published: 15 February 2022
View article titled, Abstract P5-01-03: Mouse-intraductal (MIND): An <em>in vivo</em> model for studying the underlying mechanisms of DCIS malignancy
Journal Articles

Abstract P2-01-05: Impact of post-treatment ctDNA and residual cancer burden (RCB) on outcomes in patients with triple-negative breast cancer (TNBC) and residual disease

Priyanka Sharma, Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home, Stephen Hyter, Kamilla Isakova, Harsh B Pathak, Andrew K Godwin
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-01-05.
https://doi.org/10.1158/1538-7445.SABCS21-P2-01-05
Published: 15 February 2022
View article titled, Abstract P2-01-05: Impact of post-treatment ctDNA and residual cancer burden (RCB) on outcomes in patients with triple-negative breast cancer (TNBC) and residual disease
Journal Articles

Abstract GS3-05: Classification of triple negative breast cancer (TNBC) by DNA damage immune response (DDIR) signature and homologous recombination deficiency (HRD) status: Analysis of SWOG S9313 adjuvant trial

Shane R Stecklein, William Barlow, Lajos Pusztai, Kirsten Timms, Richard Kennedy, Sunil Badve, Yesim Gökmen-Polar, Peggy Porter, Hannah Linden, Debu Tripathy, Gabriel N Hortobagyi, Andrew K Godwin, Alastair Thompson, Daniel Hayes, Priyanka Sharma
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): GS3-05.
https://doi.org/10.1158/1538-7445.SABCS20-GS3-05
Published: 15 February 2021
View article titled, Abstract GS3-05: Classification of triple negative breast cancer (TNBC) by DNA damage immune response (DDIR) signature and homologous recombination deficiency (HRD) status: Analysis of SWOG S9313 adjuvant trial
Journal Articles

Abstract GS4-07: Assessing prognosis after neoadjuvant therapy: A comparison between anatomic ypAJCC staging, residual cancer burden class and neo-bioscore

Marieke EM van der Noordaa, Christina Yau, Sonal Shad, Marie Osdoit, Tessa G Steenbruggen, Diane de Croze, Anne-Sophie Hamy, Marick Lae, Fabien Reyal, Maria Del Monte-Millán, Miguel Martin, Sara Lopez Tarruella, I-SPY 2 TRIAL Consortium, Judy C Boughey, Matthew Goetz, Tanya Hoskin, Rebecca Gould, Vincent Valero, Gabe Sonke, Maartje van Seijen, Jelle Wesseling, John Bartlett, Stephan Edge, Mi-Ok Kim, Jean Abraham, Carlos Caldas, Helena Earl, Elena Provenzano, Stephen-John Sammut, David Cameron, Ashley Graham, Peter Hall, Lorna MacKintosh, Fang Fan, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela DeMichele, Janet Dunn, Louise Hiller, Larry Hayward, Jeremy Thomas, Kimberley Cole, Lajos Pusztai, Laura van 't Veer, Fraser Symmans, Laura Esserman
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): GS4-07.
https://doi.org/10.1158/1538-7445.SABCS20-GS4-07
Published: 15 February 2021
View article titled, Abstract GS4-07: Assessing prognosis after neoadjuvant therapy: A comparison between anatomic ypAJCC staging, residual cancer burden class and neo-bioscore
Journal Articles

Abstract PD13-02: Site of recurrence after neoadjuvant therapy: A multi-center pooled analysis

Sonal Shad, Marieke van der Noordaa, Marie Osdoit, Diane de Croze, Anne-Sophie Hamy, Marick Lae, Fabien Reyal, Miguel Martin, María Del Monte-Millán, Sara López-Tarruella, I-SPY 2 TRIAL Consortium, Judy C Boughey, Matthew P Goetz, Tanya Hoskin, Rebekah Gould, Vicente Valero, Gabe Sonke, Tessa G Steenbruggen, Maartje van Seijen, Jelle Wesseling, John Bartlett, Stephen Edge, Mi-Ok Kim, Jean Abraham, Carlos Caldas, Helena Earl, Elena Provenzano, Stephen-John Sammut, David Cameron, Ashley Graham, Peter Hall, Lorna Mackintosh, Fan Fang, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela DeMichele, Janet Dunn, Louise Hiller, Larry Hayward, Jeremy Thomas, Kimberly Cole, Lajos Pusztai, Laura Van't Veer, Fraser Symmans, Laura Esserman, Christina Yau
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD13-02.
https://doi.org/10.1158/1538-7445.SABCS20-PD13-02
Published: 15 February 2021
View article titled, Abstract PD13-02: Site of recurrence after neoadjuvant therapy: A multi-center pooled analysis